Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 15/20 | 0.67 |
| ▸ | CA2 | P00918 | 15/20 | 0.67 |
| ▸ | CA9 | Q16790 | 13/20 | 0.67 |
| ▸ | CA12 | O43570 | 4/20 | 0.67 |
| ▸ | CA7 | P43166 | 4/20 | 0.67 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.67 |
| ▸ | CA3 | P07451 | 3/20 | 0.67 |
| ▸ | CA4 | P22748 | 3/20 | 0.67 |
| ▸ | CA6 | P23280 | 3/20 | 0.67 |
| ▸ | CA5A | P35218 | 3/20 | 0.67 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | GLA | P06280 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL148280 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL3354 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL41458 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL17336090 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL771183 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL2494632 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL143596 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL42396 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL147679 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL5199618 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3220876-A1 | PREPARATIONS CONTAINING ASCORBIC ACID, UBIDECARENONE AND AN EMULSIFIER MIXTURE | Beiersdorf AG (DE) | 2017-09-27 | — | — | EP | claimed |
| EP-3221013-A1 | PREPARATIONS CONTAINING ASCORBIC ACID, UBIDECARENONE AND PHOSPHATE IONS, FOR IMPROVED SKIN CONTOURING OR AGAINST CELLULITE | Beiersdorf AG (DE) | 2017-09-27 | — | — | EP | claimed |
| WO-2016078854-A1 | PREPARATIONS CONTAINING ASCORBIC ACID, UBIDECARENONE AND PHOSPHATE IONS, FOR IMPROVED SKIN CONTOURING OR AGAINST CELLULITE | BEIERSDORF AG (DE) | 2016-05-26 | — | — | WO | claimed |
| WO-2016078853-A1 | PREPARATIONS CONTAINING ASCORBIC ACID, UBIDECARENONE AND AN EMULSIFIER MIXTURE | BEIERSDORF AG (DE) | 2016-05-26 | — | — | WO | claimed |
| WO-2014183973-A1 | STABILIZED PREPARATIONS CONTAINING ASCORBIC ACID AND PHOSPHATE IONS | BEIERSDORF AG (DE) | 2014-11-20 | — | — | WO | claimed |
| WO-2014183974-A1 | STABILIZED PREPARATIONS CONTAINING ASCORBIC ACID AND MIXTURES OF SODIUM STEAROYL GLUTAMATE AND/OR CETYL STEARYL SULFATE IN COMBINATION WITH GLYCERYL STEARATE | BEIERSDORF AG (DE) | 2014-11-20 | — | — | WO | claimed |
| WO-2013032142-A9 | HIGHLY FUNCTIONAL POLYMERIZING ADDITIVE AND METHOD FOR PREPARING A VINYL CHLORIDE-BASED SEED USING SAME | (주) 엘지화학 (KR) | 2013-04-04 | — | — | WO | claimed |
| WO-2013032142-A2 | HIGHLY FUNCTIONAL POLYMERIZING ADDITIVE AND METHOD FOR PREPARING A VINYL CHLORIDE-BASED SEED USING SAME | (주) 엘지화학 (KR) | 2013-03-07 | — | — | WO | claimed |
| EP-1957037-B1 | PHARMACEUTICAL COMPOSITION FOR NASAL APPLICATION OF FENTANYL | NASALIS PAIN RELIEF INTERNAT G (DE) | 2010-04-21 | — | — | EP | claimed |
| EP-1557160-B1 | Foamable cosmetic o/w-emulsion | BEIERSDORF AG (DE) | 2007-04-04 | — | — | EP | claimed |
| EP-0841895-B1 | SLIMMING CREAM BASED ON PLANTS | DOS SANTOS MOTA JOAO CARLOS (PT) | 2003-04-09 | — | — | EP | claimed |
| EP-0786986-B1 | Use of an unsaturated fatty alcohol | NOVARTIS AG (CH) | 2002-03-20 | — | — | EP | claimed |
| EP-0736299-B1 | Process for preparing a liposomal, water-dispersable, solid, dry, therapeutic formulation for oral administration | CERBIOS PHARMA SA (CH) | 2001-11-14 | — | — | EP | claimed |
| US-5972340-A | COMPRISING SEAWEEDS, CREEPING IVY, HORSETAIL, FENUGREEK, MALLOWS, WITCH HAZEL, WHEATGERM OIL, CAMPHOR, PRESERVATIVE AND EXCIPIENT | DOS SANTOS GEORGINA (PT) | 1999-10-26 | — | — | US | claimed |
| EP-0661047-B1 | Pharmaceutical formulation containing diphenhydramine, talc, calamine and oat extract in an emulsified vehicle and uses thereof | CUSI LAB (ES) | 1998-01-28 | — | — | EP | claimed |
| EP-0131927-B1 | PHARMACEUTICAL PREPARATION CONTAINING ISOSORBIDE DINITRATE | Heinrich Mack Nachf. (DE) | 1989-10-04 | — | — | EP | claimed |
| US-12415876-B2 | Method for producing vinyl chloride-based polymer | LG CHEM, LTD. (KR) | 2025-09-16 | — | — | US | disclosed |
| US-20250161232-A1 | RETINOL FORMULATION (VI) | DSM IP ASSETS B.V. (NL) | 2025-05-22 | — | — | US | disclosed |
| US-4084052-A | HAIR DYES | L'OREAL (FR) | 1978-04-11 | — | — | US | disclosed |
| US-4023926-A | Diaminobenzoquinones in hair dye compositions | SOCIETE ANONYME DITE: L'OREAL (FR) | 1977-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250161232-A1 | RETINOL FORMULATION (VI) | RBP4, TTPA, RBP1 | CA1 4759/4885CA2 4803/4885CA9 3904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.